BBIO logo

BridgeBio Pharma, Inc. (BBIO) Free Cash Flow

Annual FCF:

-$529.63M-$608.00K(-0.11%)
December 31, 2024

Summary

  • As of today, BBIO annual free cash flow is -$529.63 million, with the most recent change of -$608.00 thousand (-0.11%) on December 31, 2024.
  • During the last 3 years, BBIO annual free cash flow has risen by +$16.55 million (+3.03%).
  • BBIO annual free cash flow is now -1193.30% below its all-time high of -$40.95 million, reached on December 31, 2017.

Performance

BBIO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Quarterly FCF:

-$112.44M-$26.67M(-31.09%)
September 30, 2025

Summary

  • As of today, BBIO quarterly free cash flow is -$112.44 million, with the most recent change of -$26.67 million (-31.09%) on September 30, 2025.
  • Over the past year, BBIO quarterly free cash flow has increased by +$69.85 million (+38.32%).
  • BBIO quarterly free cash flow is now -255.62% below its all-time high of $72.26 million, reached on June 30, 2024.

Performance

BBIO Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

TTM FCF:

-$597.61M+$69.85M(+10.47%)
September 30, 2025

Summary

  • As of today, BBIO TTM free cash flow is -$597.61 million, with the most recent change of +$69.85 million (+10.47%) on September 30, 2025.
  • Over the past year, BBIO TTM free cash flow has dropped by -$141.29 million (-30.96%).
  • BBIO TTM free cash flow is now -1703.95% below its all-time high of -$33.13 million, reached on March 31, 2018.

Performance

BBIO TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

BBIO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-0.1%+38.3%-31.0%
3Y3 Years+3.0%+17.3%-27.3%
5Y5 Years-106.7%+15.0%-54.5%

BBIO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-24.4%+3.0%-255.6%+49.1%-46.6%+10.5%
5Y5-Year-106.7%+3.0%-255.6%+49.1%-54.5%+10.5%
All-TimeAll-Time-1193.3%+3.0%-255.6%+49.1%-1704.0%+10.5%

BBIO Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$112.44M(-31.1%)
-$597.61M(+10.5%)
Jun 2025
-
-$85.78M(+57.3%)
-$667.47M(-31.0%)
Mar 2025
-
-$200.83M(-1.1%)
-$509.44M(+3.8%)
Dec 2024
-$529.63M(-0.1%)
-$198.56M(-8.9%)
-$529.63M(-16.1%)
Sep 2024
-
-$182.30M(-352.3%)
-$456.32M(-8.7%)
Jun 2024
-
$72.26M(+132.7%)
-$419.68M(+30.7%)
Mar 2024
-
-$221.03M(-76.5%)
-$605.72M(-14.5%)
Dec 2023
-$529.03M(-24.2%)
-$125.25M(+14.0%)
-$529.03M(-6.5%)
Sep 2023
-
-$145.66M(-28.0%)
-$496.70M(-2.0%)
Jun 2023
-
-$113.78M(+21.2%)
-$486.96M(-19.5%)
Mar 2023
-
-$144.33M(-55.3%)
-$407.54M(+4.3%)
Dec 2022
-$425.81M(+22.0%)
-$92.92M(+31.6%)
-$425.81M(+9.3%)
Sep 2022
-
-$135.92M(-295.6%)
-$469.32M(+5.5%)
Jun 2022
-
-$34.35M(+78.9%)
-$496.42M(+10.7%)
Mar 2022
-
-$162.61M(-19.2%)
-$556.07M(-1.8%)
Dec 2021
-$546.18M
-$136.43M(+16.3%)
-$546.18M(-7.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$163.02M(-73.4%)
-$508.16M(-6.4%)
Jun 2021
-
-$94.00M(+38.5%)
-$477.37M(-1.2%)
Mar 2021
-
-$152.73M(-55.2%)
-$471.56M(-15.8%)
Dec 2020
-$407.23M(-58.9%)
-$98.41M(+25.6%)
-$407.23M(-5.3%)
Sep 2020
-
-$132.23M(-49.9%)
-$386.77M(-27.9%)
Jun 2020
-
-$88.19M(+0.2%)
-$302.42M(-6.3%)
Mar 2020
-
-$88.40M(-13.4%)
-$284.62M(-10.0%)
Dec 2019
-$256.23M(-65.5%)
-$77.95M(-62.8%)
-$258.73M(-43.1%)
Sep 2019
-
-$47.88M(+32.0%)
-$180.78M(-5.2%)
Jun 2019
-
-$70.39M(-12.6%)
-$171.82M(-25.4%)
Mar 2019
-
-$62.50M(-60.6%)
-$137.04M(-27.3%)
Dec 2018
-$154.82M(-278.1%)
-
-
Sep 2018
-
-$38.93M(-9.3%)
-$107.67M(-56.6%)
Jun 2018
-
-$35.61M(-7.5%)
-$68.74M(-107.5%)
Mar 2018
-
-$33.13M
-$33.13M
Dec 2017
-$40.95M
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual free cash flow year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly free cash flow year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM free cash flow year-on-year change?

What is BridgeBio Pharma, Inc. annual free cash flow?

The current annual free cash flow of BBIO is -$529.63M

What is the all-time high annual free cash flow for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual free cash flow is -$40.95M

What is BridgeBio Pharma, Inc. annual free cash flow year-on-year change?

Over the past year, BBIO annual free cash flow has changed by -$608.00K (-0.11%)

What is BridgeBio Pharma, Inc. quarterly free cash flow?

The current quarterly free cash flow of BBIO is -$112.44M

What is the all-time high quarterly free cash flow for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly free cash flow is $72.26M

What is BridgeBio Pharma, Inc. quarterly free cash flow year-on-year change?

Over the past year, BBIO quarterly free cash flow has changed by +$69.85M (+38.32%)

What is BridgeBio Pharma, Inc. TTM free cash flow?

The current TTM free cash flow of BBIO is -$597.61M

What is the all-time high TTM free cash flow for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM free cash flow is -$33.13M

What is BridgeBio Pharma, Inc. TTM free cash flow year-on-year change?

Over the past year, BBIO TTM free cash flow has changed by -$141.29M (-30.96%)
On this page